How is LDL (Low-Density Lipoprotein) cholesterol calculated in an adult patient with a history of high cholesterol or cardiovascular risk factors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How LDL Cholesterol is Calculated

LDL cholesterol is most commonly calculated using the Friedewald formula: LDL-C = Total Cholesterol - HDL-C - (Triglycerides/5) when measured in mg/dL, or LDL-C = Total Cholesterol - HDL-C - (Triglycerides/2.2) when measured in mmol/L. 1

The Friedewald Formula

The standard calculation method endorsed by European and American guidelines uses the following equations 1, 2:

  • In mg/dL: LDL-C = Total Cholesterol - HDL-C - (Triglycerides/5)
  • In mmol/L: LDL-C = Total Cholesterol - HDL-C - (Triglycerides × 0.45)

This formula assumes that the ratio of triglycerides to cholesterol in VLDL particles is 5:1 when measured in mg/dL 3, 4.

Critical Limitations of the Friedewald Formula

The Friedewald calculation becomes invalid when triglycerides exceed 4.5 mmol/L (400 mg/dL), as the triglyceride-to-cholesterol ratio in VLDL particles progressively increases with worsening hypertriglyceridemia. 1, 3

Additional Accuracy Concerns

  • The calculated LDL-C systematically underestimates true LDL-C by approximately 20 mg/dL on average compared to direct measurement, with this discrepancy increasing as triglycerides rise 5
  • In patients with triglycerides 0.51-2.00 g/L, using a divisor of 4.5 instead of 5 provides better accuracy 4
  • Female sex, elevated body mass index, and age in the fifth-sixth decades result in greater underestimation 5

When to Use Alternative Methods

For patients with triglycerides >4.5 mmol/L (400 mg/dL), or LDL-C <70 mg/dL, use direct LDL-C measurement or newer calculation methods like the Sampson-NIH2 equation (valid up to triglycerides of 9 mmol/L). 6, 2, 3

Newer Calculation Methods

  • Sampson-NIH2 equation: Derived using beta-quantification and can be used with triglycerides up to 9 mmol/L 3
  • Martin-Hopkins equation: Uses 180-cell stratification and can be used with triglycerides up to 4.5 mmol/L (extended version up to 9.04 mmol/L) 3

Clinical Impact on Treatment Decisions

Direct LDL-C measurements can differ by approximately 15% from calculated values, which is clinically significant for determining whether patients meet treatment goals. 1, 6

Treatment Goal Misclassification

  • Approximately 50% of high-risk patients who appear to meet their LDL goal by calculated method actually fail to meet goal when measured directly 5
  • When using the Friedewald formula with triglycerides ≤4.00 g/L, only 86% of patients are properly classified according to treatment cutpoints 4

Special Considerations in Treated Patients

Lipid-lowering medications alter the mathematical relationships between lipid components, making calculated LDL-C less accurate in patients on statin therapy. 6

  • Statins specifically alter LDL particle composition and cholesterol content per particle 6
  • Most LDL-C methods incorrectly count cholesterol in Lp(a) particles as "LDL-C," overestimating true LDL-C particularly in treated patients 6
  • Patients with metabolic syndrome have discordant LDL-C and LDL particle numbers, with normal calculated LDL-C but higher particle numbers 6

Practical Algorithm for Clinical Use

  1. For routine screening and most patients: Use the Friedewald formula if triglycerides <4.5 mmol/L (400 mg/dL) 1

  2. For high triglycerides (>400 mg/dL): Use direct LDL-C measurement or calculate non-HDL-C (Total Cholesterol - HDL-C) as an alternative target 1

  3. For very low LDL-C (<70 mg/dL) or treated high-risk patients: Consider direct measurement or Sampson-NIH2 equation for greater accuracy 6, 3

  4. When direct measurement unavailable: Use non-HDL-C as the treatment target, which doesn't require triglyceride levels and may better predict cardiovascular risk 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Utility of Total Cholesterol to HDL Ratio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Best practice for LDL-cholesterol: when and how to calculate.

Journal of clinical pathology, 2023

Guideline

Estimating Small Dense LDL-C in Treated Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.